Landmark Case in Germany: BioNTech Faces Lawsuit Over COVID-19 Vaccine Side Effects

In a landmark development, BioNTech SE, the German biotechnology company that partnered with Pfizer Inc. to produce one of the first COVID-19 vaccines, is now facing its first legal challenge in Germany over vaccine side effects. 

In an unprecedented case that could potentially spark hundreds of similar claims across Germany, the plaintiff – a woman who has chosen to remain anonymous due to Germany’s privacy laws – is suing BioNTech for a minimum of €150,000 ($161,500) in damages. 

According to Reuters, she cites “damages for bodily harm as well as compensation for unspecified material damage,” as detailed by Hamburg’s regional court and the law firm representing her, Rogert & Ulbrich.

GRTWT.